Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 312

Vizient to Present at FDA Hearing on the Future of Insulin Biosimilars

Posted by fidest press agency su martedì, 14 maggio 2019

Vizient Inc. announces that Steven Lucio, PharmD, BCPS, vice president, pharmacy solutions, will present on behalf of the company and its member hospitals at the Food and Drug Administration’s (FDA) public hearing “The Future of Insulin Biosimilars: Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products,” being held from 9 a.m. to 2:45 p.m. today at the FDA White Oak Campus in Silver Spring, Maryland. The hearing will give industry experts the opportunity to offer insights to the FDA on how to facilitate the development of insulin biosimilars and other interchangeable insulin products to address the soaring cost for these life-saving medications for diabetic patients.
Since 2010, Vizient has provided ongoing training and education on the biosimilar paradigm to its provider members in the form of over 200 in-person presentations and web conferences. We have also developed evidence-based clinical resources to support members in their formulary evaluations of approved and pending biosimilars, and we’ve worked with existing and future biosimilar manufacturers on contractual relationships to maximize the value and cost savings opportunities for our membership. At present, Vizient has over 50 pharmacists and other subject matter expert resources working to facilitate the appropriate use of biosimilars and document the financial value and sustained high quality care associated with these agents.
Vizient is the nation’s largest health care performance improvement company serving a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health care delivery networks and non-acute health care providers.


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: